Cue Biopharma, Inc. Common Stock (NASDAQ: CUE) last traded at $23.98, down 2.56% on the session. The quote above updates while this page is open; the figures below are drawn from Cue Biopharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Cue Biopharma, Inc. Common Stock trades on NASDAQ under the ticker CUE. Its market capitalisation is $174.20 million.
Valuation measures for Cue Biopharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $174.20M |
|---|---|
| Enterprise value | $185.21M |
| Price / sales | 4.63 |
| Price / book | 75.41 |
| Beta | 3.04 |
Trailing-twelve-month figures tagged in Cue Biopharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $37.65M |
|---|---|
| Net income (TTM) | -$164.11M |
| EPS (TTM) | -$17.88 |
| Operating margin | -262.03% |
| Return on equity | -7104.24% |
| Cash | $17.39M |
Range and volume for CUE over the past 52 weeks.
| 52-week high | $45.50 |
|---|---|
| 52-week low | $4.98 |
| Volume | 177.1K |
| Average volume | 143.7K |
| Previous close | $24.61 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.